Skip to content

EPS (Basic) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$4.44+11.3%
Danaher logo
DanaherDHR
$1.45+9.0%
Agilent Technologies logo
Agilent TechnologiesA
$1.20+60.0%
Illumina logo
IlluminaILMN
$0.88+6.0%
TEC
Bio-TechneTECH
$0.33+136%
Revvity logo
RevvityRVTY
$0.36+2.9%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%
Enterprise value$5.44B+30.4%
P/S13.3×+0.7×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's EPS (basic)?
Twist Bioscience Corporation (TWST) reported EPS (basic) of -$0.71 in Q1 2026.
How has Twist Bioscience Corporation's EPS (basic) changed year-over-year?
Twist Bioscience Corporation's EPS (basic) decreased by 7.6% year-over-year, from -$0.66 to -$0.71.
What is the long-term trend for Twist Bioscience Corporation's EPS (basic)?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's EPS (basic) has grown at a -19.8% compound annual growth rate (CAGR), from -$3.15 to -$1.30.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.